163.80
price down icon0.41%   -0.67
after-market アフターアワーズ: 163.80
loading
前日終値:
$164.47
開ける:
$164.31
24時間の取引高:
1.49M
Relative Volume:
1.21
時価総額:
$18.64B
収益:
$9.54B
当期純損益:
$841.00M
株価収益率:
22.02
EPS:
7.44
ネットキャッシュフロー:
$1.02B
1週間 パフォーマンス:
-0.03%
1か月 パフォーマンス:
-5.58%
6か月 パフォーマンス:
+9.96%
1年 パフォーマンス:
+29.00%
1日の値動き範囲:
Value
$162.47
$165.59
1週間の範囲:
Value
$161.60
$169.69
52週間の値動き範囲:
Value
$125.42
$178.87

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
名前
Quest Diagnostics Inc
Name
セクター
Healthcare (1151)
Name
電話
(973) 520-2700
Name
住所
500 PLAZA DRIVE, SECAUCUS
Name
職員
56,000
Name
Twitter
@QuestDX
Name
次回の収益日
2025-04-22
Name
最新のSEC提出書
Name
DGX's Discussions on Twitter

DGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
163.80 18.64B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.50 169.62B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
186.83 138.06B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
411.49 32.79B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
102.48 29.99B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
143.91 26.61B 15.41B 1.37B 2.11B 7.50

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 開始されました Redburn Atlantic Buy
2025-03-04 ダウングレード Citigroup Buy → Neutral
2025-01-06 アップグレード Leerink Partners Market Perform → Outperform
2024-12-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました Jefferies Buy
2024-10-23 アップグレード Robert W. Baird Neutral → Outperform
2024-08-28 再開されました Evercore ISI In-line
2024-07-10 アップグレード Citigroup Neutral → Buy
2024-02-26 開始されました Leerink Partners Market Perform
2024-02-07 アップグレード Jefferies Hold → Buy
2024-01-03 開始されました Barclays Equal Weight
2023-12-12 アップグレード BofA Securities Neutral → Buy
2023-06-29 開始されました Piper Sandler Neutral
2023-05-02 ダウングレード BofA Securities Buy → Neutral
2023-04-03 アップグレード Citigroup Sell → Neutral
2023-01-23 開始されました Evercore ISI In-line
2022-11-17 ダウングレード Citigroup Neutral → Sell
2022-08-22 再開されました Morgan Stanley Equal-Weight
2022-04-04 ダウングレード Citigroup Buy → Neutral
2022-02-23 ダウングレード UBS Buy → Neutral
2022-02-02 ダウングレード Jefferies Buy → Hold
2022-01-28 ダウングレード Deutsche Bank Buy → Hold
2021-05-04 アップグレード UBS Neutral → Buy
2021-03-12 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-21 アップグレード Argus Hold → Buy
2020-07-29 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 アップグレード BofA Securities Neutral → Buy
2020-06-09 アップグレード Wells Fargo Underweight → Equal Weight
2020-06-02 アップグレード Deutsche Bank Hold → Buy
2020-04-28 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-04-27 アップグレード Citigroup Neutral → Buy
2020-04-27 アップグレード Wolfe Research Underperform → Peer Perform
2020-03-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-01-08 開始されました Wells Fargo Underweight
2020-01-07 ダウングレード Barclays Overweight → Equal Weight
2019-12-19 アップグレード BofA/Merrill Underperform → Neutral
2019-07-15 ダウングレード Goldman Neutral → Sell
2019-04-02 アップグレード Jefferies Hold → Buy
2019-03-18 再開されました Credit Suisse Neutral
2019-01-31 ダウングレード Argus Buy → Hold
2019-01-17 開始されました UBS Neutral
2019-01-03 ダウングレード BofA/Merrill Neutral → Underperform
2018-12-03 ダウングレード BofA/Merrill Buy → Neutral
2018-11-30 ダウングレード Goldman Buy → Neutral
すべてを表示

Quest Diagnostics Inc (DGX) 最新ニュース

pulisher
09:13 AM

Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - Yahoo

09:13 AM
pulisher
Apr 17, 2025

Quest Diagnostics Declares Quarterly Cash Dividend - Quantisnow

Apr 17, 2025
pulisher
Apr 17, 2025

Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.

Apr 17, 2025
pulisher
Apr 16, 2025

Peering Into Quest Diagnostics's Recent Short Interest - Benzinga

Apr 16, 2025
pulisher
Apr 15, 2025

Price Over Earnings Overview: Quest Diagnostics - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Quest Diagnostics price target raised to $198 from $190 at BofA - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings - Yahoo Finance

Apr 15, 2025
pulisher
Apr 14, 2025

Quest Diagnostics (DGX): Price Target Increased to $198 by BofA Analyst | DGX Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 14, 2025
pulisher
Apr 10, 2025

Quest introduces blood test to confirm amyloid brain pathology in Alzheimer’s - Medical Device Network

Apr 10, 2025
pulisher
Apr 09, 2025

Quest Diagnostics (NYSE:DGX) Unveils New Alzheimer's Blood Test With Promising Predictive Accuracy - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease - PR Newswire

Apr 09, 2025
pulisher
Apr 09, 2025

Revolutionary Blood Test Transforms Alzheimer's Diagnosis: Quest's New 91%-Accurate Solution - Stock Titan

Apr 09, 2025
pulisher
Apr 08, 2025

Here's What to Expect From Quest Diagnostics’ Next Earnings Report - MSN

Apr 08, 2025
pulisher
Apr 08, 2025

Quest Diagnostics : To Speak At The 38th Annual J.P. Morgan Healthcare Conference - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 07, 2025

Compensation Up For Quest Diagnostics GC After Earlier Dip - Law360

Apr 07, 2025
pulisher
Apr 07, 2025

Quest Diagnostics (DGX) Shares Cross 2% Yield Mark - Nasdaq

Apr 07, 2025
pulisher
Apr 07, 2025

Here's What To Expect From Quest Diagnostics’ Next Earnings Report - Barchart.com

Apr 07, 2025
pulisher
Apr 05, 2025

Lobbying Update: $80,000 of QUEST DIAGNOSTICS INCORPORATED lobbying was just disclosed - Nasdaq

Apr 05, 2025
pulisher
Apr 05, 2025

Quest Diagnostics CEO sells $6.6 million in stock By Investing.com - Investing.com South Africa

Apr 05, 2025
pulisher
Apr 04, 2025

Quest Diagnostics CEO sells $6.6 million in stock - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Quest Diagnostics SVP Karthik sells $434,350 in stock By Investing.com - Investing.com Canada

Apr 04, 2025
pulisher
Apr 04, 2025

Quest Diagnostics SVP Karthik sells $434,350 in stock - Investing.com

Apr 04, 2025
pulisher
Apr 03, 2025

Quest Diagnostics' (NYSE:DGX) Dividend Will Be Increased To $0.80 - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Ex-Dividend Reminder: Quest Diagnostics, Preferred Bank and Erie Indemnity - Nasdaq

Apr 03, 2025
pulisher
Apr 02, 2025

Redburn Atlantic Initiates Quest Diagnostics at Buy With $195 Price Target - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Passed Our Checks, And It's About To Pay A US$0.80 Dividend - Yahoo

Apr 02, 2025
pulisher
Apr 02, 2025

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Redburn Atlantic initiated coverage on Quest Diagnostics with a new price target - Quantisnow

Apr 02, 2025
pulisher
Apr 02, 2025

Quest Revolutionizes Cervical Cancer Screening with New Self-Collection Test - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 - Nasdaq

Apr 01, 2025
pulisher
Mar 31, 2025

Quest Health Review 2025: Services, Pricing, and Reliability - Healthline

Mar 31, 2025
pulisher
Mar 31, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Mar 31, 2025
pulisher
Mar 29, 2025

Is Quest Diagnostics Stock Outperforming the S&P 500? - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

SVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 162 shares, decreasing direct ownership by 0.77% to 20,988 units (SEC Form 4) - Quantisnow

Mar 28, 2025
pulisher
Mar 27, 2025

Is Quest Diagnostics Stock Worth Holding Onto Right Now? - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Nephron Research Downgrades Quest Diagnostics to Hold From Buy, $184 Price Target - Marketscreener.com

Mar 27, 2025
pulisher
Mar 26, 2025

Is Quest Diagnostics Stock Outperforming The S&P 500? - Barchart.com

Mar 26, 2025
pulisher
Mar 26, 2025

Truist maintains hold on Quest Diagnostics stock, $182 target By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 23, 2025

Quest Diagnostics (DGX) and Google Cloud to Transform Healthcare Data with AI - Insider Monkey

Mar 23, 2025
pulisher
Mar 21, 2025

DGX Stock Set to Benefit From New Google Cloud Partnership - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Top 8 AI News Updates Investors Shouldn’t Miss - Insider Monkey

Mar 20, 2025
pulisher
Mar 20, 2025

What 9 Analyst Ratings Have To Say About Quest Diagnostics - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance - AlphaStreet

Mar 20, 2025

Quest Diagnostics Inc (DGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Quest Diagnostics Inc (DGX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
Apr 02 '25
Sale
170.00
2,555
434,350
10,575
diagnostics_research LH
$217.12
price down icon 1.56%
diagnostics_research WAT
$321.01
price down icon 0.03%
$148.08
price down icon 1.39%
diagnostics_research MTD
$1,004.96
price down icon 1.15%
diagnostics_research IQV
$143.91
price down icon 3.05%
大文字化:     |  ボリューム (24 時間):